FRSX
Foresight Autonomous Holdings Ltd.
There isn't enough reported data to score FRSX yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
FRSX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
FRSX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
FRSX PE Valuation
FRSX has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
FRSX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| -- | |
| Limited | |
| High |
Analysts expect FRSX's losses to grow, with revenue declining.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
FRSX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$0.50 | +$0.35 |
| Q4 2024 | -$0.50 | +$0.76 |
| Q2 2024 | -$0.85 | +$3.50 |
| Q4 2023 | -$1.26 | +$7.20 |
| Q2 2023 | -$4.35 | +$3.33 |
| Q4 2022 | -$8.46 | -$3.00 |
| Q2 2022 | -$7.68 | -$1.38 |
| Q4 2021 | -$5.46 | +$3.36 |
FRSX has the edge over RIVN in the latest year-over-year earnings comparison.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
FRSX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $158K | -25% |
| Q2 2025 | $240K | +7.1% |
| Q4 2024 | $212K | -52% |
| Q2 2024 | $224K | +307% |
| Q4 2023 | $442K | +46% |
| Q2 2023 | $55K | -78% |
FRSX's revenue has slid since its 2023 peak: $158,000 last quarter, down 64% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -3789% | -2138 points |
| Q2 2025 | -2581% | +13775 points |
| Q4 2024 | -3097% | -172 points |
| Q2 2024 | -2728% | +749 points |
| Q4 2023 | -1650% | N/A |
| Q2 2023 | -16356% | N/A |
| Q4 2022 | -2925% | N/A |
| Q2 2022 | -3476% | N/A |
FRSX's operating margin was −3789% last quarter, down 2138 points from the same quarter a year ago.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over FRSX in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
FRSX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$5.1M | +$859K |
| Q2 2025 | -$5.4M | -$220K |
| Q4 2024 | -$6M | +$1M |
| Q2 2024 | -$5.2M | +$2.9M |
| Q4 2021 | -$6.5M | -$776K |
| Q2 2021 | -$5.8M | -$39K |
| Q4 2020 | -$5.8M | +$460K |
| Q2 2020 | -$5.8M | -$41K |
FRSX has burned cash in almost every quarter: −$22M over the past year, against −$27M the year before.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
FRSX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +23% | +5.1M shares |
| 1 year | +968% | +24.8M shares |
FRSX has 27M diluted shares, up 968% from a year ago.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has the edge over FRSX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
FRSX Net Leverage
FRSX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FRSX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.9 | Oversold |
| Stochastic | 6.7 | Oversold |
FRSX's weekly RSI is 21 (oversold) and its Stochastic is 7 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
FRSX PE vs Consumer Cyclical Sector
FRSX has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
FRSX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.82 | 30% below |
| 20 week MA | $1.12 | 49% below |
| 50 week MA | $2.16 | 74% below |
| 100 week MA | $7.77 | 93% below |
| 200 week MA | $21.1 | 97% below |
FRSX is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
FRSX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $132.3 | $632.5 | +378% |
| 2021 | $632.5 | $235.6 | -63% |
| 2022 | $235.6 | $64.3 | -73% |
| 2023 | $64.3 | $21.6 | -66% |
| 2024 | $21.6 | $38.6 | +79% |
| 2025 | $38.6 | $4.50 | -88% |
| 2026 YTD | $4.50 | $0.57 | -87% |
FRSX's yearly returns have swung widely, from +378% in 2020 to −88% in 2025. It's down 87% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over FRSX on returns for 2026, with the stronger performance.